Harrell’s C-statistics for evaluation of overall adequacy of risk prediction procedures
| Protein | Model 3 vs model with add-on of each protein |
| GDF-15 | 0.693 vs 0.694 |
| MMP-2 | 0.693 vs 0.698 |
| UPAR | 0.693 vs 0.695 |
| OPN | 0.693 vs 0.701 |
| IGFBP-7 | 0.693 vs 0.696 |
| PON3 | 0.693 vs 0.693 |
| TNFR1 | 0.693 vs 0.693 |
| NT-proBNP | 0.693 vs 0.750 |
| CHI3L1 | 0.693 vs 0.693 |
| FABP-4 | 0.693 vs 0.696 |
| GAL-4 | 0.693 vs 0.694 |
| Z-score | 0.693 vs 0.701 |
Model 3 is adjusted for age, sex, body mass index, systolic blood pressure, smoking status, prevalent diabetes mellitus, prevalent coronary events, prevalent heart failure and antihypertensive treatment.
CHI3L1, chitinase-3-like protein 1; FABP4, fatty-acid binding protein 4; GAL-4, galectin 4; GDF-15, growth differentiation factor 15; IGFBP-7, insulin-like growth factor-binding protein 7; MMP-2, matrix metalloproteinase-2; NT-proBNP, N-terminal pro-B-type natriuretic peptide; OPN, osteopontin; PON3, paraoxonase 3; TNFR1, tumour necrosis factor receptor 1; UPAR, urokinase receptor.